Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA Meanwhile, NASEM sounds “SOS” for health infrastructure

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Over the past seven years, as Steven K. Libutti was designing the 12-story, $900-plus million cancer hospital in New Brunswick, NJ, he often thought of the functionality of the building that inspired it: Building 10, the NIH Clinical Center.

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models.

April 25, 2025

Vol.51 No.16

By Claire Marie Porter

Cancer Policy

HHS said it would terminate Women’s Health Initiative, then reconsidered

On April 21, Women’s Health Initiative investigators were informed that HHS would be terminating the WHI Regional Center contracts at the end of the current fiscal year.

April 25, 2025

Vol.51 No.16

By Jacquelyn Cobb and Claire Marie Porter

Cancer Policy

DOJ letters to peer-reviewed journals allege partisan bias in medical literature

At least two medical journals have received letters from the Trump administration accusing them of political bias.

April 25, 2025

Vol.51 No.16

By Claire Marie Porter

Cancer Policy

ASCO seeks to engage new leaders of NIH, CMS, and FDA

The Association for Clinical Oncology has reached out to the new leaders of federal health agencies to ensure continued progress in cancer care, research, and patient access, the organization said.

NIH notice prohibits grant awardees from operating programs that promote DEI

NIH, in a recent notice, prohibits grant recipients from operating programs that promote DEI or “discriminatory equity ideology,” or engage in “discriminatory prohibited boycott.”

April 25, 2025

Vol.51 No.16

By Jacquelyn Cobb

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA

Meanwhile, NASEM sounds “SOS” for health infrastructure

YOU MAY BE INTERESTED IN

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

HHS said it would terminate Women’s Health Initiative, then reconsidered

DOJ letters to peer-reviewed journals allege partisan bias in medical literature

ASCO seeks to engage new leaders of NIH, CMS, and FDA

NIH notice prohibits grant awardees from operating programs that promote DEI

Renew today!

Subscriber content

Never miss an issue!

Login

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA

Meanwhile, NASEM sounds “SOS” for health infrastructure

YOU MAY BE INTERESTED IN

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

HHS said it would terminate Women’s Health Initiative, then reconsidered

DOJ letters to peer-reviewed journals allege partisan bias in medical literature

ASCO seeks to engage new leaders of NIH, CMS, and FDA

NIH notice prohibits grant awardees from operating programs that promote DEI

Never miss an issue!

Login

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas